COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age—Propensity Score-Matched Analysis of Austrian National Public Health Institute Data
Authors:
- Faisal AzizFAFaisal Aziz
- Felix AbererFAFelix Aberer
- Alexander BräuerABAlexander Bräuer
- Christian CiardiCCChristian Ciardi
- Martin ClodiMCMartin Clodi
- Peter FaschingPFPeter Fasching
- Mario KarolyiMKMario Karolyi
- Alexandra Kautzky-WillerAlexandra Kautzky-Willer
- Carmen KlammerCKCarmen Klammer
- Oliver MalleOMOliver Malle
- Erich PawelkaEPErich Pawelka
- Thomas PieberTPThomas Pieber
Open Access
Abstract
Background: It is a matter of debate whether diabetes alone or its associated comorbidities are responsible for severe COVID-19 outcomes. This study assessed the impact of diabetes on intensive care unit (ICU) admission and in-hospital mortality in hospitalized COVID-19 patients. Methods: A retrospective analysis was performed on a countrywide cohort of 40,632 COVID-19 patients hospitalized between March 2020 and March 2021. Data were provided by the Austrian data platform. The association of diabetes with outcomes was assessed using unmatched and propensity-score matched (PSM) logistic regression. Results: 12.2% of patients had diabetes, 14.5% were admitted to the ICU, and 16.2% died in the hospital. Unmatched logistic regression analysis showed a significant association of diabetes (odds ratio [OR]: 1.24, 95% confidence interval [CI]: 1.15–1.34, p < 0.001) with in-hospital mortality, whereas PSM analysis showed no significant association of diabetes with in-hospital mortality (OR: 1.08, 95%CI: 0.97–1.19, p = 0.146). Diabetes was associated with higher odds of ICU admissions in both unmatched (OR: 1.36, 95%CI: 1.25–1.47, p < 0.001) and PSM analysis (OR: 1.15, 95%CI: 1.04–1.28, p = 0.009). Conclusions: People with diabetes were more likely to be admitted to ICU compared to those without diabetes. However, advanced age and comorbidities rather than diabetes itself were associated with increased in-hospital mortality in COVID-19 patients.Keywords
This publication has 27 references indexed in Scilit:
- Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysisDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering MedicationDiabetes Care, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Diabetes is a risk factor for the progression and prognosis of COVID‐19Diabetes/Metabolism Research and Reviews, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary AtherosclerosisScientific Reports, 2017
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- Comorbidity Measures for Use with Administrative DataMedical Care, 1998